High-Purity 3-(4-Methyl-1H-Imidazol-1-yl)-5-(Trifluoromethyl)Aniline: Your Key Nilotinib Intermediate

Discover a critical component for advanced pharmaceutical synthesis. We are a leading supplier of 3-(4-Methyl-1H-Imidazol-1-yl)-5-(Trifluoromethyl)Aniline (CAS 641571-11-1), an essential intermediate for Nilotinib production. Ensure your research and manufacturing processes benefit from our high-quality, reliably sourced chemical intermediates.

Get a Quote & Sample

Key Advantages of Partnering with Us

Uncompromising Quality

We ensure that every batch of 3-(4-Methyl-1H-Imidazol-1-yl)-5-(Trifluoromethyl)Aniline (CAS 641571-11-1) meets rigorous purity standards (≥98.0%), crucial for successful Nilotinib synthesis. As your trusted chemical manufacturer, we guarantee product integrity.

Reliable Supply Chain

Count on us for a stable and dependable supply of this vital pharmaceutical intermediate. We understand the importance of consistent availability for your production schedules. Purchase with confidence from our China-based operations.

Competitive Commercial Terms

We offer competitive pricing for 3-(4-Methyl-1H-Imidazol-1-yl)-5-(Trifluoromethyl)Aniline. Engage with us to buy this Nilotinib intermediate and explore our attractive supplier terms. Get a quote today.

Primary Application

Nilotinib Synthesis

This compound is a cornerstone intermediate in the multi-step synthesis of Nilotinib, a critical medication in targeted cancer therapy. We provide reliable sourcing for this key building block.

Pharmaceutical Intermediates

As a specialized supplier, we cater to the pharmaceutical industry's need for high-quality intermediates, ensuring purity and consistency for complex drug manufacturing processes.

Advanced Organic Synthesis

Researchers and formulators utilize this trifluoromethylated aniline for various advanced organic synthesis projects, leveraging its unique chemical structure and reactivity.

Custom Synthesis Support

Beyond standard supply, we offer expertise in custom synthesis, providing tailored solutions for specific project requirements in pharmaceutical R&D.